Amanda Giddings
About Amanda Giddings
Amanda Giddings is a Senior Principal Scientist at BenevolentAI in Cambridge, England, with over 10 years of experience in non-clinical safety within the pharmaceutical industry.
Current Role at BenevolentAI
Amanda Giddings is a Senior Principal Scientist at BenevolentAI, operating from the research facility in Cambridge, England, United Kingdom. In her role, she leverages her extensive expertise in computational toxicology and non-clinical safety within the pharmaceutical industry. BenevolentAI utilizes a unique computational R&D platform that integrates into every step of the drug discovery process, underscoring Giddings' significant contributions.
Previous Experience as Computational Toxicologist
Prior to her current role, Amanda Giddings served as a Computational Toxicologist from 2010 to 2021 in Ware, UK. During her 11-year tenure, she focused on toxicological risk assessments, evaluating the safety of impurities throughout the drug development process. Her work has significantly influenced non-clinical safety in the pharmaceutical sector.
Earlier Role as Genetic Toxicologist
From 2007 to 2010, Amanda Giddings worked as a Genetic Toxicologist in Ware, England, United Kingdom. In this capacity, she concentrated on genetic toxicology studies, contributing to foundational research that supported drug safety evaluations.
Research Associate at Trigen Ltd
Amanda Giddings was a Research Associate at Trigen Ltd from 2006 to 2007. Her one-year engagement involved participating in diverse research projects, further enhancing her capabilities in toxicology and research methodologies.
Educational Background in Biochemistry and Toxicology
Amanda Giddings holds a BSc in Biochemistry with Toxicology from the University of Surrey, which she completed between 1999 and 2003. Her educational foundation in biochemistry and toxicology provided a solid basis for her future roles in toxicological research and risk assessment within the pharmaceutical industry.